Gilead Sciences Inc (GILD) financials · rev $29.44B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Gilead Sciences Inc (GILD) rev $29.44B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $29.44B | $28.75B |
| Cost of Revenue | $6.23B | $6.25B |
| Gross Profit | $23.21B | $22.50B |
| Operating Income | $10.02B | $1.66B |
| Net Income | $8.51B | $480.0M |
| EPS (Diluted) | $6.78 | $0.38 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $59.02B | $58.99B |
| Current Assets | $18.34B | $19.17B |
| Inventory | $1.77B | $1.71B |
| PP&E | $5.61B | $5.41B |
| Total Liabilities | $36.32B | $39.66B |
| Current Liabilities | $11.81B | $12.00B |
| Short-term Debt | $2.81B | $1.81B |
| Long-term Debt | $22.13B | $24.90B |
| Total Debt | $24.94B† | $26.71B† |
| Shareholders' Equity | $22.70B | $19.33B |
| Retained Earnings | $13.73B | $11.50B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $10.02B | $10.83B |
| CapEx | $563.0M | $523.0M |
| Investing Cash Flow | -$4.79B | -$3.45B |
| Financing Cash Flow | -$7.75B | -$3.43B |
| Dividends Paid | $4.00B | $3.92B |
| Net Change in Cash | -$2.43B | $3.91B |
| Free Cash Flow | $9.46B | $10.30B |
FAQ
What is GILD P/E and revenue?
Gilead Sciences Inc (GILD) rev $29.44B.
What is GILD revenue?
Gilead Sciences Inc last cached revenue is $29.44B (FY2025).
Is GILD profitable?
Gilead Sciences Inc last cached net income is $8.51B (FY2025).
What are GILD total assets?
Gilead Sciences Inc last cached total assets are $59.02B (FY2025).
What is GILD free cash flow?
Gilead Sciences Inc last cached free cash flow is $9.46B (FY2025).
Not investment advice. Cached statements, not a live tape.